NBI-1117568

· Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for NBI-1117568, covering 2025-07-11 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia [Phase 3]